Major Shareholder of Tempest Therapeutics Sells Nearly 400,000 Shares
TLDR: Tempest Therapeutics major shareholder Versant Venture Capital Vi, L. sold 387,999 shares of the firm’s stock. The shares were sold at an average price of $1.10, totaling $426,798.90. A major shareholder